Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and due from banks	$ 8,087,000	$ 12,062,000
Federal funds sold	16,047,000	4,616,000
Total cash and cash equivalents	24,134,000	16,678,000
Investment securities available for sale, at fair value	135,953,000	133,853,000
Restricted stock, at cost	2,190,000	1,564,000
Loans held for sale	1,852,000	2,268,000
Loans
Outstandings		538,427,000
Allowance for credit losses		(3,370,000)
Deferred costs, net		588,000
Total loans, net		535,645,000
Loans
Outstandings	539,818,000
Allowance for credit losses	(3,272,000)
Deferred costs, net	647,000
Total loans, net	537,193,000
Premises and equipment, net	11,806,000	11,748,000
Bank owned life insurance	12,866,000	12,798,000
Accrued interest receivable	3,574,000	3,651,000
Other assets	5,229,000	5,065,000
Total Assets	734,797,000	723,270,000
Deposits
Noninterest bearing demand	254,039,000	255,236,000
Interest bearing	363,977,000	369,507,000
Total deposits	618,016,000	624,743,000
Long-term debt - trust preferred securities	8,764,000	8,764,000
Subordinated debt, net	5,700,000	5,692,000
Federal Home Loan Bank advances	35,000,000	20,000,000
Accrued interest payable	212,000	70,000
Other liabilities	3,224,000	2,890,000
Total liabilities	670,916,000	662,159,000
Shareholders' equity
Common stock, $4 par value, 10,000,000 shares authorized; 1,485,813 shares issued and outstanding at March 31, 2023 and 1,482,790 shares issued and outstanding at December 31, 2022	5,881,000	5,868,000
Additional paid-in capital	55,256,000	55,167,000
Retained earnings	12,141,000	10,957,000
Stock in directors rabbi trust	(595,000)	(689,000)
Directors deferred fees obligation	595,000	689,000
Accumulated other comprehensive loss	(9,397,000)	(10,881,000)
Total shareholders' equity	63,881,000	61,111,000
Total liabilities and shareholders' equity	$ 734,797,000	$ 723,270,000